OCLR and Scheimpflug-Placido topographer effective for corneal measurements - Ophthalmology Times Europe

ADVERTISEMENT

CATARACT

GLAUCOMA

REFRACTIVE

RETINA

OCLR and Scheimpflug-Placido topographer effective for corneal measurements

Ophthalmology Times Europe

Using an optical low-coherence reflectometry (OLCR) biometer and Scheimpflug-Placido topographer are both as effective for measuring corneal parameters, claims a study in the Journal of Cataract and Refractive Surgery.

Dr Wuhe Chen et al., Eye Hospital of Wenzhou Medical College, Wenzhou, China, evaluated 40 subjects. One randomly healthy eye of each participant was measured three times with both devices.

The parameters measured included central corneal thickness (CCT), anterior chamber depth (ACD) from the corneal epithelium and from the endothelium, mean keratometry (K) and white-to-white (WTW) corneal diameter.

Within-subject standard deviation was used to calculate the repeatability of the scans. Agreement between the two devices was evaluated using the Bland-Altman limits of agreement (LoA) method. A mean of three scans were performed in order to assess LoA.

Repeatability of the Scheimpflug-Placido topographer and OLCR biometer was 3.10 μm and 3.32 μm for CCT. For WTW corneal diameter was 0.04 mm and 0.05 mm and for mean K it was 0.17 D and 0.10 D for mean K for the the Scheimpflug-Placido topographer and OLCR biometer, respectively.

According to the Bland-Altman LoA analysis, all parameters were within clinically sufficient limits. Both devices presented good repeatability for all parameters and can be used interchangeably between parameters.

On a scale of 1 to 10, with 1 being the lowest and 10 being the highest, how would you rate this article?
Your original vote has been tallied and is included in the ratings results.
View our top pages
Average rating for this page is: 6
WHAT DO YOU THINK?

AddThis Social Bookmark Button

Rate this article
Your comments
Discuss on our forum
Follow us on Twitter

 

Survey
Would you use topical cocaine to treat symptomatic anterior basement membrane dystrophy?
Yes
No
Yes
50%
No
50%
Source: Ophthalmology Times Europe,
Click here